Veracyte, Inc. (VCYT) Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Core Insights - Veracyte has experienced significant growth in 2025, with Decipher growing by 32% year-to-date and Afirma by 9% year-to-date, indicating strong performance across its core business segments [2]. Business Performance - The company has achieved numerous accomplishments in 2025, feeling positive about its current position compared to the beginning of the year [2]. - The growth in the core business is described as encouraging and impressive, reflecting the company's successful strategies and market positioning [2].